Skip to content

Clinical trial of the effect of breathing exercise on expiratory force and abdominal muscle in stroke patients

Effect of Respiratory Muscle Training on expiratory muscle strength and abdominal electrical activity in the acute phase of Stroke: randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8w44f6
Enrollment
Unknown
Registered
2019-10-02
Start date
2019-10-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Control group: 20 patients, both genders with Ischemic Stroke, will undergo only conventional physical therapy for 5 consecutive days, once in the morning lasting 30 minutes. Procedures: Mobilization:
Device
E02.190.525.186
E02.779

Sponsors

Hospital das Clínicas da Faculdade de Medicina de Botucatu - UNESP
Lead Sponsor
lorena
Collaborator
Hospital das Clínicas da Faculdade de Medicina de Botucatu - UNESP
Collaborator

Eligibility

Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 years and under 80 years of age admitted to the stroke unit of the Clinical Hospital of the Botucatu Medical School, with clinical diagnosis of ischemic stroke by magnetic resonance or computed tomography with up to 80 years will be evaluated. 72 hours of the ictus, absence of disability prior to hospitalization with score less than or equal to 1 in eMR, item 1a (level of consciousness), 1c (Commands: open / close eyes, shake and release hand), language and facial paresis NIHSS less than equal to 1, no previous dementia or other associated neuromuscular diseases, no severe valvulopathy and previous major thoracic or abdominal surgery under 1 year, no congestive heart failure class III and IV, no asthma or decompensated chronic obstructive pulmonary disease (COPD) with a closed diagnosis.

Exclusion criteria

Exclusion criteria: Patients with previous complaints of dysphagia, clinical instability, invasive mechanical ventilation or palliative care will be excluded, those who fail to perform the MIP / MEP assessment protocol, ventilometry, non-adaptation to training, worsening of clinical and hemodynamic status and those who do not agree to participate in the study or refuse to continue the training.

Design outcomes

Primary

MeasureTime frame
Primary outcome The primary outcome to be evaluated is respiratory function through expiratory muscle strength, through a Support® brand manovacuometer (São Paulo, Brazil) with an operating range of ± 120 cmH2O, and maximum expiratory pressure (MEP) and inspiratory pressure were measured. maximum (MIP) within 72h.

Secondary

MeasureTime frame
Secondary outcomes The following secondary outcomes will be assessed: muscle electrical activity of the abdomen muscles, assessed by superficial electromyography; CV by the ventilometer; FPM; eMR functional disability; individual autonomy for self-care by IB; severity of neurological status by NIHSS; QOL by EUROQOL, sequentially on the first day and the fifth day after intervention.

Countries

Brazil

Contacts

Public ContactLorena Sartor

Hospital das Clínicas da Faculdade de Medicina de Botucatu - UNESP

lorenasartor@hotmail.com551438801246

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 14, 2026